IPN10200, IPN10200 placebo
CLIN-10200-454
Phase 2 small_molecule active
Quick answer
IPN10200, IPN10200 placebo for Episodic Migraine Chronic Migraine is a Phase 2 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ipsen Pharma
- Indication
- Episodic Migraine Chronic Migraine
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active